NEXI OTC
NexImmune, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -0.0%
1Y: -50.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1M
+31.5% ▲
Operating Income
-$29M
+53.7% ▲
Net Income
-$32M
-106.3% ▼
EPS (Diluted)
$-30.82
-105.8% ▼
EBITDA
-$28M
+53.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $436K | $619K | $870K | $1M | $1M |
| Gross Profit | -$436K | -$619K | -$870K | -$1M | -$1M |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $15M | $18M | $37M | $47M | $18M |
| SG&A Expenses | $6M | $10M | $16M | $16M | $10M |
| Operating Expenses | $21M | $27M | $52M | $62M | $28M |
| Operating Income | -$21M | -$28M | -$53M | -$63M | -$29M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $2M | $905K | $0 | $0 |
| Income Before Tax | -$21M | -$30M | -$51M | -$63M | -$32M |
| Tax Expense | -$247K | $2M | $844K | -$577M | $0 |
| Net Income | -$20M | -$32M | -$52M | $514M | -$32M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-22.53 | $-34.76 | $-56.67 | $534.29 | $-30.82 |
| EBITDA | -$20M | -$28M | -$49M | -$61M | -$28M |
| Shares Outstanding | 900861 | 910311 | 913156 | 962364 | 1M |